Comparison Study in Pancreatic Fiducial Placement

Withdrawn before enrolling · Not applicable

Conditions studied: Pancreatic Neoplasms

In brief

Comparison Study between 19 gauge EUS FNA BNX Needle vs. 22 gauge EUS FNA BNX Needle in Pancreatic Fiducial Placement To Treat Pancreatic Cancer

Key facts

Study ID

NCT02376543

Run by

Parkview Health

People needed

0

Starts

2015-03-06

Expected to finish

2019-03-15

Last updated by the study team

2020-09-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects that plan to undergo CyberKnife treatment for pancreatic cancer
• Subjects that are deemed physically able to undergo anesthesia (either Monitored Anesthesia Care (MAC) or general anesthesia)
• Subjects (or the subjects Legally Authorized Representative [LAR]) that have agreed to participate in the study and have signed Informed Consent
• Subjects 18 years of age or older
• Subject must be able to hold anticoagulants as per institutional standard of care
• Women of child bearing potential who are not pregnant as proven by a negative pregnancy test

You may not qualify if…

• Subjects that are unable to tolerate anesthesia for the procedure
• Subjects 17 or under
• Subjects that refuse treatment for pancreatic cancer d Subjects whose anticoagulants cannot be held
• e. Subjects who have distant metastatic disease f. Subjects who cannot or refuse EUS guided procedures. g Subjects who are pregnant

Where it is running

• Parkview Cancer Institute — Fort Wayne, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.